Clinical Trials Logo

Filter by:
NCT ID: NCT00121667 Completed - Clinical trials for Diabetes Mellitus, Type 2

Study Assessing Saxagliptin Treatment In Type 2 Diabetic Subjects Who Are Not Controlled With Metformin Alone

Start date: August 2005
Phase: Phase 3
Study type: Interventional

The purpose of this clinical research study is to learn whether Saxagliptin added to Metformin therapy is more effective than Metformin alone as a treatment for type 2 diabetic subjects who are not sufficiently controlled with Metformin alone

NCT ID: NCT00119652 Completed - Depression Clinical Trials

Seroquel in Bipolar Depression Versus SSRI

EMBOLDEN II
Start date: May 2005
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine whether quetiapine is effective and safe in the acute treatment of bipolar depression and whether the effect is maintained when treatment is continued.

NCT ID: NCT00117598 Completed - Lymphoma Clinical Trials

Study Evaluating Temsirolimus (CCI-779) In Mantle Cell Lymphoma (MCL)

OPTIMAL
Start date: May 2005
Phase: Phase 3
Study type: Interventional

This is an open-label, randomized trial in relapsed refractory subjects with mantle cell lymphoma (MCL).

NCT ID: NCT00115791 Completed - Atrial Fibrillation Clinical Trials

Study to Determine the Response and Effectiveness of RSD1235 in Subjects With Atrial Fibrillation or Atrial Flutter

Start date: June 2004
Phase: Phase 3
Study type: Interventional

The purpose of this study is to demonstrate the effectiveness of RSD1235 compared with placebo, in the conversion of atrial fibrillation or atrial flutter to sinus rhythm.

NCT ID: NCT00114777 Completed - Clinical trials for Renal Transplantation

Study of Belatacept in Subjects Who Are Undergoing a Renal Transplant

BENEFIT-EXT
Start date: February 2005
Phase: Phase 3
Study type: Interventional

The purpose of this trial is to learn if Belatacept is effective and safe as a first line of immunosuppression treatment in patients undergoing a renal transplant where the donor kidney is obtained in patients with extended criteria.

NCT ID: NCT00113815 Completed - Epilepsy Clinical Trials

Topiramate as Adjunctive Therapy in Infants 1-24 Months for the Control of Partial Onset Seizures

Start date: May 2005
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the tolerability, safety and efficacy of topiramate in infants with refractory partial onset seizures (POS).

NCT ID: NCT00113607 Completed - Ovarian Cancer Clinical Trials

An Efficacy and Safety Study for Yondelis (Trabectedin) in Patients With Advanced Relapsed Ovarian Cancer

Start date: April 2005
Phase: Phase 3
Study type: Interventional

The purpose of the study is to compare the progression-free survival (PFS) of the combination of trabectedin + DOXIL with DOXIL monotherapy in patients with ovarian cancer.

NCT ID: NCT00113490 Completed - Clinical trials for Motavizumab Administration for a Second Season for RSV Prophylaxis

A Study to Evaluate the Safety, Tolerability, and Immunogenicity of Motavizumab (MEDI-524) After Dosing for a Second Season in Children

Start date: May 2005
Phase: Phase 1/Phase 2
Study type: Interventional

The primary objective of this study was to determine the effect on immune reactivity to motavizumab (MEDI-524) of monthly intramuscular (IM) doses of motavizumab (MEDI-524) administered for a second season in children.

NCT ID: NCT00113308 Completed - Clinical trials for Arthritis, Rheumatoid

COX-2 Inhibitor Study In Patients With Rheumatoid Arthritis

Start date: June 2005
Phase: Phase 3
Study type: Interventional

This study is being conducted to find out if an investigational drug called GW406381 can help people with rheumatoid arthritis.

NCT ID: NCT00113165 Completed - Epilepsy Clinical Trials

Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures

Start date: October 2004
Phase: Phase 3
Study type: Interventional

This study is being conducted to compare the efficacy and safety of LAMICTAL (lamotrigine) extended-release with placebo in the treatment of partial seizures. LAMICTAL extended-release is an investigational drug. Placebo tablets look like LAMICTAL extended-release tablets but do not contain active medication. In this study, LAMICTAL extended-release or placebo tablets will be added to current seizure treatments.